News
Amarin’s Vazkepa secures NICE recommendation
Vazkepa – also known as icosapent ethyl – has been recommended by the National Institute for Health and Care Excellence (NICE) for use across the NHS in England and Wales to reduce cardiovascular disease (CVD) risk.